GMP Issues: Breaking Ground

by Paula Shadle, Shadle Consulting When building a biotech manufacturing facility and a QC lab, which scenario do you choose ? build manufacturing first, build the QC lab first, or build both facilities simultaneously?

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 22 years ago

Article

Virus Inactivation in the 1990s and into the 21st Century

over 22 years ago

Article

Using Peptide Maps as Identity and Purity Tests for Lot Release Testing of Recombinant Therapeutic Proteins

over 22 years ago

Article

Getting Ready for Risk-Based GMPs

over 22 years ago

Article

Guest Editorial: Benchmarking Biotech

over 22 years ago

Article

Optimized Nutrient Additives for Fed-Batch Cultures

over 22 years ago

Article

Commercial Production of Transgenic Crops Genetically Engineered to Produce Pharmaceuticals

over 22 years ago

Article

Inside Washington: GMP Progress Report

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

GMP Issues: Breaking Ground

Articles in this issue

Newsletter